Arrow Financial Corp Regeneron Pharmaceuticals, Inc. Transaction History

Arrow Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 28, 2019	SELL	$273.46 - $318.39 $180,483 - $210,137	-660 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$372.08 - $439.57 $223,248 - $263,742	600 Added 1000.0%	660 $271,000
Q1 2018 Apr 25, 2018	BUY	$315.82 - $393.78 $18,949 - $23,626	60 New	60 $21,000
Q4 2017 Feb 05, 2018	SELL	$358.63 - $469.95 $35,863 - $46,995	-100 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$431.38 - $504.0 $43,138 - $50,400	100	100 $45,000

1,532

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Arrow Financial Corp with notifications on news.